Literature DB >> 34751042

Proteomic Distributions in CD34+ Microvascular Niche Patterns of Glioblastoma.

Jintao Chen1,2,3, Sifeng Mao2, Ziyi He2, Lijuan Yang4, Jinfeng Zhang3, Jin-Ming Lin2, Zhi-Xiong Lin1.   

Abstract

The poor clinical prognosis and microvascular patterns of glioblastoma (GBM) are of serious concern to many clinicians and researchers. However, very few studies have examined the correlation between microvascular niche patterns (MVNPs) and proteomic distribution. In this study, CD34 immunofluorescence staining and matrix-assisted laser desorption ionization-mass spectrometry imaging (MALDI-IMS) technology were used to investigate the protein distributions in MVNPs. CD34+ microvascular phenotype could be divided into four types: microvascular sprouting (MS), vascular cluster (VC), vascular garland (VG), and glomeruloid vascular proliferation (GVP). Based on such characteristics, MVNPs were divided into two types by cluster analysis, namely, type I, comprising primarily MS and VC, and type II, comprising many VGs and GVPs. Survival analysis indicated the type of MVNPs to be an independent prognostic factor for progression-free and overall survival in GBM. MALDI-IMS results showed the peaks at m/z 1037 and 8960 to exhibit stronger ion signals in type II, while those at m/z 3240 and 3265 exhibited stronger ion signals in type I. The findings may assist future research on therapy and help predict prognosis in GBM. However, due to the limited number of studies, more well-designed studies are warranted to further verify our results.

Entities:  

Keywords:  MALDI-imaging MS; angiogenesis; glioblastoma; microvascular; prognosis; stem cell; stemness; tumor heterogeneity; tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 34751042      PMCID: PMC8721573          DOI: 10.1369/00221554211058098

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  26 in total

1.  Angiogenic patterns and their quantitation in high grade astrocytic tumors.

Authors:  Suash Sharma; Mehar C Sharma; Deepak Kumar Gupta; Chitra Sarkar
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

2.  N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.

Authors:  Arun V Everest-Dass; Matthew T Briggs; Gurjeet Kaur; Martin K Oehler; Peter Hoffmann; Nicolle H Packer
Journal:  Mol Cell Proteomics       Date:  2016-07-13       Impact factor: 5.911

3.  DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.

Authors:  Ji-Liang Li; Richard C A Sainson; Chern Ein Oon; Helen Turley; Russell Leek; Helen Sheldon; Esther Bridges; Wen Shi; Cameron Snell; Emma T Bowden; Herren Wu; Partha S Chowdhury; Angela J Russell; Craig P Montgomery; Richard Poulsom; Adrian L Harris
Journal:  Cancer Res       Date:  2011-07-29       Impact factor: 12.701

4.  Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.

Authors:  Long Chen; Zhi-Xiong Lin; Guo-Shi Lin; Chang-Fu Zhou; Yu-Peng Chen; Xing-Fu Wang; Zong-Qing Zheng
Journal:  Hum Pathol       Date:  2014-10-14       Impact factor: 3.466

Review 5.  MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.

Authors:  R R Drake; T W Powers; E E Jones; E Bruner; A S Mehta; P M Angel
Journal:  Adv Cancer Res       Date:  2016-12-20       Impact factor: 6.242

6.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

7.  Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.

Authors:  Peter Birner; Maria Piribauer; Ingeborg Fischer; Brigitte Gatterbauer; Christine Marosi; Peter F Ambros; Inge M Ambros; Markus Bredel; Georg Oberhuber; Karl Rössler; Herbert Budka; Adrian L Harris; Johannes A Hainfellner
Journal:  Brain Pathol       Date:  2003-04       Impact factor: 6.508

8.  Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy.

Authors:  Frank Saran; Olivier L Chinot; Roger Henriksson; Warren Mason; Wolfgang Wick; Timothy Cloughesy; Sunita Dhar; Emanuela Pozzi; Josep Garcia; Ryo Nishikawa
Journal:  Neuro Oncol       Date:  2016-01-24       Impact factor: 12.300

Review 9.  A review of glioblastoma immunotherapy.

Authors:  Ravi Medikonda; Gavin Dunn; Maryam Rahman; Peter Fecci; Michael Lim
Journal:  J Neurooncol       Date:  2020-04-06       Impact factor: 4.130

10.  MALDI MSI Reveals the Spatial Distribution of Protein Markers in Tracheobronchial Lymph Nodes and Lung of Pigs after Respiratory Infection.

Authors:  Tomas Do; Roman Guran; Rea Jarosova; Petra Ondrackova; Zbysek Sladek; Martin Faldyna; Vojtech Adam; Ondrej Zitka
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.